ArticleCancer immunology, immunotherapy : CII2010

Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.

A Mander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.